Eiger BioPharmaceuticals, Inc.

OTCPK:EIGR.Q Stock Report

Market Cap: US$12.6m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Eiger BioPharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:EIGR.Q Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Jun 24SellUS$1,029,771Moshe ArkinIndividual96,300US$13.17

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EIGR.Q?
Owner TypeNumber of SharesOwnership Percentage
Institutions148,77310%
Individual Insiders251,17517%
General Public1,080,84973%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 22 shareholders own 27.01% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.1%
Moshe Arkin
149,371US$1.3m181%no data
6.08%
Simplify Asset Management Inc.
90,000US$765.0k0%0.06%
3.81%
Propel Bio Management, LLC
56,381US$479.2k0%0.67%
2.21%
Richard Kayne
32,793US$278.7k0%no data
2.1%
David Apelian
31,032US$263.8k8,360%no data
0.76%
Jeffrey Glenn
11,296US$96.0k0%no data
0.4%
David Cory
5,971US$50.8k0%no data
0.37%
Eldon Mayer
5,551US$47.2k197%no data
0.36%
Thomas Dietz
5,365US$45.6k127%no data
0.27%
James Vollins
4,000US$34.0k0%no data
0.099%
Evan Loh
1,466US$12.5k214%no data
0.099%
Amit Sachdev
1,466US$12.5k175%no data
0.077%
Kim Sablich
1,133US$9.6k467%no data
0.075%
Perinvest (UK) Ltd
1,116US$9.5k0%0.01%
0.073%
DFPG Investments, Inc., Asset Managment Arm
1,080US$9.2k0%no data
0.048%
Sriram Ryali
714US$6.1k0%no data
0.044%
Ingrid Choong
650US$5.5k0%no data
0.025%
Christine Murray
367US$3.1k0%no data
0.0055%
Securities America Advisors, Inc.
81US$688.50%no data
0.0043%
Bg Fund Management Luxembourg S.A.
63US$534.90%no data
0.0029%
Osaic Wealth, Inc. , Asset Management Arm
43US$365.0-82.8%no data
0.00061%
Woodbury Financial Services, Inc, Securities Investments
9US$76.80%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/02 16:21
End of Day Share Price 2024/10/01 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eiger BioPharmaceuticals, Inc. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Brian SkorneyBaird
Madhu KumarB. Riley Securities, Inc.